biopharmafund

59 results found.

Top Stocks matching your search for "biopharma fund"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
GNUS

Genius Brands International Inc

-61.31%

$6.54 - $2.53

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 20, 2023

Monopar Therapeutics (NASDAQ:MNPR) stock is rising... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
AMAM

Ambrx Biopharma

485.88%

$1.70 - $9.96

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 6, 2023

$AMAM Ambrx Biopharma Shares Halted On Circuit Br... See more

Dec, 10, 2022

Biopharma is hot.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
AYTU

Aytu BioPharma Inc

-36.39%

$3.27 - $2.08

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Nov, 17, 2022

"We are extremely pleased to be part of the p... See more

Nov, 17, 2022

$AYTU Aytu BioPharma First Quarter 2023 Earnings... See more

GNUS

Genius Brands International Inc

-61.31%

$6.54 - $2.53

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 20, 2023

Monopar Therapeutics (NASDAQ:MNPR) stock is rising close to 19% this morning.

AMAM

Ambrx Biopharma

485.88%

$1.70 - $9.96

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 6, 2023

$AMAM Ambrx Biopharma Shares Halted On Circuit Breaker To The Upside, Stock Now Up 69%

Dec, 10, 2022

Biopharma is hot.

AYTU

Aytu BioPharma Inc

-36.39%

$3.27 - $2.08

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Nov, 17, 2022

"We are extremely pleased to be part of the prestigious Deloitte Technology Fast 500 list of most rapidly growing companies," commented Josh Disbrow, Chief Executive Officer of Aytu BioPharma.

Nov, 17, 2022

$AYTU Aytu BioPharma First Quarter 2023 Earnings: Beats Expectations! https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aytu/aytu-biopharma/news/aytu-biopharma-first-quarter-2023-earnings-beats-expectation

Nov, 14, 2022

$AYTU "This was truly a transformational quarter for Aytu as we reported record quarterly net revenue and our first ever positive Adjusted EBITDA quarter," commented Josh Disbrow, Chief Executive Officer of Aytu BioPharma.